History of CRO Dr. Kottmann

The Clinical Research Organisation Dr. Kottmann is a full-service CRO. It was foundend and – until her leaving the company end of 2023 – lead by the internist/cardiologist Dr. Tanja Kottmann. Since 2017, we have been expanding very strongly: While initially clinical studies were conducted in the German-speaking region, we have been offering full service throughout Europe and additionally in the Middle East and Africa since 2019.

We have many long-standing cooperation partners such as universities, professional societies and manufacturers of medical devices and pharmaceuticals with whom we have planned numerous projects and with whom we always see ourselves as consultants for the planning and implementation of clinical studies.

Our CRO is interested in long-term cooperations and also follows the requirements of small and medium-sized companies. Many of our clients are medical device manufacturers, whom we support with advice and assistance in implementing the requirements of MDR and carry out both clinical evaluations and clinical studies.

We are continuously inspired by innovations and realize new ways of doing research projects together with our partners. We have a high potential of long term academic staff with excellent expertise that we can bring to your project. This enables us to implement even large projects promptly and optimally.

 

Branch Office in Ahlen

In autumn 2019, we opened an office building with 600 sqm of office capacity in a central location with excellent transport connections in Ahlen/Westphalia.

We have now successfully completed more than 2000 projects - full service or partial services - in which we have either taken over data management, medical writing, regulatory affairs, monitoring or all services as part of a complete project management.

In 2023, RQM+, a global leader in MedTech services, announces its acquisition of CRO Kottmann. This significant move further supports RQM+’s dedication to strategic growth and presence in Europe and emphasizes its dominance in the growing areas of MedTech. RQM+ is the world's leading MedTech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product lifecycle. RQM+’s global team of clinical, technical, and top industry experts push the boundaries of excellence. With more former FDA, Medicines, and Healthcare Products Regulatory Agency (MHRA) and notified body regulators than any other firm, the RQM+ team has deep expertise in all clinical specialties. We reduce commercialization risk by offering a full complement of CRO services to progress medical devices, digital therapeutics and diagnostics onto the market and keep them there.

Our experience:

  • Full-Service-Projecs
  • Data base creations (eCRFs)
  • Clinical Monitoring
  • Literature research
  • Clinical evaluations
  • GCP trainings
  • Document preparation - Medical Writing (study plan preparation, interim reports, final reports)
  • Medical statistics

Subject areas of previous studies:

 

We are looking forward to further projects, developments and challenges.